Dr. Georgios Lainas participated as a speaker at the ESHRE Campus held in Vienna on March 21–22, 2025, focusing on the latest developments in the diagnosis and management of Polycystic Ovary Syndrome (PCOS)—from fundamental knowledge to advanced therapeutic strategies.
The ESHRE (European Society of Human Reproduction and Embryology) workshop, which took place from 31 October to 2 November 2024 at the Divani Palace Hotel in Athens, was successfully concluded.
13-15 September 2024
Jaipur , India
Building bridges between continents
George Lainas, MD, PhD, Scientific Director of IVF unit "Eugonia" gave a satellite lecture at the 10th Panhellenic Conference on Ultrasound in Obstetrics held in Heraklion, Crete (27-29 September 2024).
May 31 - June 2
Constantinople
George Lainas, Scientific Director of IVF "Eugonia" received an honorary invitation from the Turkish society for Fertility Preservation for the annual conference in Istanbul.
A very important distinction was made by Eugonia Assisted Reproduction Unit for the proposal submitted to the SME Instruments of the HORIZON 2020 program in Phase 1 regarding the use of AI in the evaluation of embryos, further strengthening its presence in the Hellenic Medical Area as well as Internationally.
This suggestion has been refined in all assessment categories in one of the most demanding programs where less than 5% of participants manage to distinguish themselves.
HORIZON 2020's "SME Instruments" is the largest European Research and Innovation Program available, with available funding amounting to € 80 billion, for the seven-year period 2014-2020.
Dr. George Lainas, gynecologist at Eugonia, will be the coordinator of ESHRE and specifically of the Special Interest Group "Reproductive Endocrinology" for the next two years (2019-2021).
ESHRE (European Society of Human Reproduction and Embryology) is a global organization that defines developments in the wider field of Assisted Reproduction worldwide.
This distinction is the international recognition of Eugonia's scientific and clinical work over the last 20 years of its action, which aims at the benefit of every couple who trusts our team to fulfill their dream of having a child.
The scientific team of Eugonia has developed an innovative treatment for severe Ovarian Hyperstimulation Syndrome, eliminating the risk of complications (according to 5 published studies of our team). This treatment has been established internationally as the tertiary level for the management of OHSS, and is considered as the only available treatment of the syndrome worldwide.
See more
88% per blastocyst transferred, for women below 35 years old
See more
In more detail: in our Unit, initiation of antagonist administration is decided according to individualized criteria and is associated with statistically higher pregnancy rates.
Our study was published in Human Reproduction, official journal of ESHRE (European Society of Human Reproduction and Embryology).
See the publication
The international scientific organization FACULTY of 1000 MEDICINE, which reviews clinical studies, has positively assessed a published study of our team.
See more
Our team has published two of the largest studies (by number of patients included) in the international bibliography, with regards to the new ovarian stimulation treatment for women with poor response and polycystic ovaries.
There is detailed report of 2 studies of our team in the journal of Human Reproduction.
Our study regarding the best ovarian stimulation protocol, had a special mention by the Editor of the journal Human Reproduction.
See more
The first twins born by a paraplegic man were conceived in our center using sperm taken by electroejaculation.
Eugonia is the first Greek IVF Clinic certified for ISO EN 15224:2012 in the field of health, regarding patient’s safety, treatment effectiveness and quality system improvement.
Eugonia - Assisted Reproduction Unit
Konstantinou Ventiri 7(HILTON), 11528 Athens
Member of:
